This FOA invites applications from groups of two (2) or more institutions to participate in a clinical studies program to improve the long-term outcome of transplant recipients (thoracic organ, abdominal organ and vascular composite tissue). The Clinical Trials in Organ Transplantation (CTOT) program will support a cooperative, multi-institutional consortium for the conduct of interventional trials (Phase 1, 2, or 3) or observational clinical studies in organ or vascularized composite allotransplantation (VCA). Each clinical study must include associated mechanistic studies that focus on immune-mediated pathologic processes in allotransplantation or on mechanisms of immune activation and quiescence. The goals of this research will be to target immune-mediated causes of morbidity and mortality in transplant recipients and evaluate interventions to address them.
As the School of Medicine may only submit 1 proposal for this opportunity, the Office of Research and Graduate Education has established an internal review process to determine which proposal(s) will move forward to the funding agency.
To apply for this funding opportunity, please email the following to RGE at firstname.lastname@example.org by Wednesday, September 18, 2013.
Applicants will be notified as soon as a decision is reached. The selected applicants must adhere to OSP’s deadlines outlined in GIM-19: http://www.washington.edu/research/osp/gim/gim19.html
Investigators who identify a grant, award or fellowship program that restricts the number of applications that can be submitted from an Institution should immediately contact their Chairperson, Associate Dean for Research (or Dean, if no ADR) and the Office of Research (see below) if they intend to prepare a response. Failure to do so, or to meet the deadlines for submission of pre-proposal, will preclude submission of the application through the Office of Sponsored Programs.
For general inquiries, or to request a listing of a limited submission opportunity that should be but is not already listed, please email us at email@example.com.